Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-02-24

FDA Approved: QUTENZA — Supplemental Application (Averitas Pharma Inc)

View source ↗

Summary

FDA approved a supplemental application for QUTENZA (capsaicin) submitted by Averitas Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUTENZA (Capsaicin)

Snippet

SUPPL AP for QUTENZA (CAPSAICIN)